← Return to Adverse effects of ADT for aggressive tumors
DiscussionAdverse effects of ADT for aggressive tumors
Prostate Cancer | Last Active: 4 days ago | Replies (18)Comment receiving replies
Replies to "All great information. I'll just add that the second generation ARSIs (the so-called "-lutamides") have had..."
After my fourth reoccurrence, I was put on abiraterone. It Only got my PSA down to undetectable one time in 2 1/2 years but for 2 1/2 years it did not fail me and gave me 2 1/2 more years of very low PSA numbers before I moved onto Darolutamide.
With someone who has had reoccurrences it’s just a matter of time before the drug they pick (Zytigaor a lutamide) stops working, That’s the one thing we all face if you have advanced prostate cancer. Your cancer will eventually defeat the drug you are on and you have to move on to something different. I may get four years on Darolutamide Before my PSA starts to rise again, But Zytiga gave me another 2 1/2 years since I started with it. Very unlikely Darolutamide will work for 6.5 years. That is a hypothetical, Darolutamide May not last me four years, but whatever amount of time it gives me zytiga gave me 2 1/2 more years without reoccurrence.
Yes, the side effects of Zytiga aren’t desirable, but going there first can give more time before stronger measures are needed.
Then there is the Lancet article I have posted many times that recommends the best sequence is Zytiga followed by a lutamide.
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30688-6/abstract?mc_cid=c2dca8aa74&mc_eid=99575fc699
I was taken off zytiga after 11 months because I suffered a heart attack. (Gleason 8 with cribiforms, stage 3tb)
Do lutamides affect the heart like zytiga?